Search Results

There are 12189 results for: content related to: Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B

  1. Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 7, July 2014, Pages: 1485–1493, Jeong Heo, Sang Hoon Ahn, Young-Oh Kweon, Byung-Ho Kim, Henry L Y Chan, Andrzej Horban, Suchat Wongcharatrawee, Cyril Llamoso and Kwan Sik Lee

    Version of Record online : 15 JUL 2014, DOI: 10.1111/jgh.12567

  2. Comparison of the efficacies of entecavir 0.5 and 1.0 mg combined with adefovir in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analogue treatments

    Journal of Medical Virology

    Volume 87, Issue 6, June 2015, Pages: 999–1007, Yuri Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Hyo-Suk Lee and Yoon Jun Kim

    Version of Record online : 24 FEB 2015, DOI: 10.1002/jmv.24150

  3. Efficacy and Pharmacokinetics of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B and Renal Impairment

    The Journal of Clinical Pharmacology

    Volume 51, Issue 9, September 2011, Pages: 1293–1301, Dr Mitchell L. Shiffman MD, Dr Stanislas Pol, Dr Lionel Rostaing, Dr Eugene Schiff, Dr Dominique Thabut, Dr Stefan Zeuzem, Dr Jian Zong, Dr David Frederick and Dr Franck Rousseau

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010381385

  4. You have free access to this content
    Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

    Hepatology

    Volume 54, Issue 1, July 2011, Pages: 91–100, Yun-Fan Liaw, Maria Raptopoulou-Gigi, Hugo Cheinquer, Shiv Kumar Sarin, Tawesak Tanwandee, Nancy Leung, Cheng-Yuan Peng, Robert P. Myers, Robert S. Brown Jr, Lennox Jeffers, Naoky Tsai, Jolanta Bialkowska, Shijie Tang, Suzanne Beebe and Elizabeth Cooney

    Version of Record online : 24 JUN 2011, DOI: 10.1002/hep.24361

  5. Five years of treatment with adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B

    Liver International

    Volume 32, Issue 1, January 2012, Pages: 137–146, Zeng Minde, Mao Yimin, Yao Guangbi, Hou JinLin, Wang Hao, Ren Hong, Wang Yuming, Zhou Xiaqiu, Xu Daozhen, Chen Yagang, Niu Junqi, Chen Youming, Wang Yaozong, Jonathan Dixon and Keith Barker

    Version of Record online : 19 SEP 2011, DOI: 10.1111/j.1478-3231.2011.02641.x

  6. Failure of adefovir 20 mg to improve suboptimal response in lamivudine-resistant hepatitis B patients treated with adefovir 10 mg and lamivudine

    Journal of Viral Hepatitis

    Volume 15, Issue 12, December 2008, Pages: 922–924, M. Viganò, P. Lampertico, F. Facchetti, G. Lunghi and M. Colombo

    Version of Record online : 6 OCT 2008, DOI: 10.1111/j.1365-2893.2008.01047.x

  7. Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: Clonal evolution during lamivudine plus adefovir therapy

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 55–64, Soon Sun Kim, Sung Won Cho, Soo-Ok Kim, Sun Pyo Hong and Jae Youn Cheong

    Version of Record online : 23 OCT 2012, DOI: 10.1002/jmv.23440

  8. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 40–45, Jia-Jie Lu, Kai Liu, Yuan-Ji Ma, Juan Wang, En-Qiang Chen and Hong Tang

    Version of Record online : 4 MAR 2013, DOI: 10.1111/jvh.12062

  9. You have free access to this content
    Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir

    Hepatology

    Volume 49, Issue 1, January 2009, Pages: 72–79, Nancy Leung, Cheng-Yuan Peng, Hie-Won Hann, Jose Sollano, Judy Lao-Tan, Chao-Wei Hsu, Laurentius Lesmana, Man-Fung Yuen, Lennox Jeffers, Morris Sherman, Albert Min, Kimberly Mencarini, Ulysses Diva, Anne Cross, Richard Wilber and Juan Lopez-Talavera

    Version of Record online : 26 SEP 2008, DOI: 10.1002/hep.22658

  10. Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy

    Liver International

    Volume 34, Issue 10, November 2014, Pages: 1543–1549, Mi Na Kim, Chun Kyon Lee, Sang Hoon Ahn, Sangheun Lee, Seung Up Kim, Do Young Kim, Hyon Suk Kim, Kwang-Hyub Han, Chae Yoon Chon and Jun Yong Park

    Version of Record online : 12 JAN 2014, DOI: 10.1111/liv.12437

  11. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26856

  12. A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 14, Issue 2, February 2007, Pages: 75–88, A. Takeda, J. Jones, J. Shepherd, P. Davidson and A. Price

    Version of Record online : 10 NOV 2006, DOI: 10.1111/j.1365-2893.2006.00808.x

  13. Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: A 4-year study

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 1, January 2010, Pages: 54–60, Themistoklis G Vassiliadis, Olga Giouleme, Georgios Koumerkeridis, Haralabos Koumaras, Konstantinos Tziomalos, Kalliopi Patsiaoura, Nikolaos Grammatikos, Alexandros Mpoumponaris, Dimitrios Gkisakis, Konstantinos Theodoropoulos, Athanasia Panderi, Panagiotis Katsinelos and Nikolaos Eugenidis

    Version of Record online : 22 SEP 2009, DOI: 10.1111/j.1440-1746.2009.05952.x

  14. Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir

    Liver International

    Volume 32, Issue 7, August 2012, Pages: 1179–1185, Chang Young Son, Han Jak Ryu, Jung Min Lee, Sang Hoon Ahn, Do Young Kim, Myoung Ha Lee, Kwang Hyub Han, Chae Yoon Chon and Jun Yong Park

    Version of Record online : 27 MAR 2012, DOI: 10.1111/j.1478-3231.2012.02793.x

  15. Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B

    Journal of Medical Virology

    Volume 84, Issue 1, January 2012, Pages: 18–25, Soon Sun Kim, Jae Youn Cheong, Dami Lee, Myoung Hee Lee, Sun Pyo Hong, Soo-Ok Kim and Sung Won Cho

    Version of Record online : 25 OCT 2011, DOI: 10.1002/jmv.22227

  16. You have free access to this content
    Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B

    Hepatology

    Volume 48, Issue 3, September 2008, Pages: 750–758, Patrick Marcellin, Ting-Tsung Chang, Seng G. Lee Lim, William Sievert, Myron Tong, Sarah Arterburn, Katyna Borroto-Esoda, David Frederick and Franck Rousseau

    Version of Record online : 16 MAY 2008, DOI: 10.1002/hep.22414

  17. You have free access to this content
    Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 3, February 2008, Pages: 266–273, S. MANOLAKOPOULOS, S. BETHANIS, S. KOUTSOUNAS, J. GOULIS, J. VLACHOGIANNAKOS, E. CHRISTIAS, A. SAVERIADIS, C. PAVLIDIS, C. TRIANTOS, A. CHRISTIDOU, G. PAPATHEODORIDIS, D. KARAMANOLIS and D. TZOURMAKLIOTIS

    Version of Record online : 6 NOV 2007, DOI: 10.1111/j.1365-2036.2007.03567.x

    Corrected by:

    Corrigenda

    Vol. 27, Issue 6, 528–529, Version of Record online: 20 FEB 2008

  18. Rescue therapy for lamivudine-resistant chronic hepatitis B: Comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 8, August 2010, Pages: 1374–1380, Hong Joo Kim, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon and Byung Ik Kim

    Version of Record online : 14 MAY 2010, DOI: 10.1111/j.1440-1746.2010.06381.x

  19. Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial

    Journal of Viral Hepatitis

    Volume 22, Issue 2, February 2015, Pages: 85–93, J. L. Hou, Z. L. Gao, Q. Xie, J. M. Zhang, J. F. Sheng, J. Cheng, C. W. Chen, Q. Mao, W. Zhao, H. Ren, D. M. Tan, J. Q. Niu, S. J. Chen, C. Pan, H. Tang, H. Wang, Y. M. Mao, J. D. Jia, Q. Ning, M. Xu, S. M. Wu, J. Li, X. X. Zhang, Y. Ji, J. Dong and J. Li

    Version of Record online : 22 SEP 2014, DOI: 10.1111/jvh.12313

  20. Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance

    Journal of Medical Virology

    Volume 84, Issue 3, March 2012, Pages: 424–430, Hyo-Joon Yang, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon and Hyo-Suk Lee

    Version of Record online : 13 JAN 2012, DOI: 10.1002/jmv.23229